financetom
Business
financetom
/
Business
/
Rhythm Pharmaceuticals Insider Sold Shares Worth $619,851, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rhythm Pharmaceuticals Insider Sold Shares Worth $619,851, According to a Recent SEC Filing
Jul 11, 2025 1:50 PM

04:42 PM EDT, 07/11/2025 (MT Newswires) -- Joseph Shulman, Chief Technical Officer, on July 09, 2025, sold 7,969 shares in Rhythm Pharmaceuticals ( RYTM ) for $619,851. Following the Form 4 filing with the SEC, Shulman has control over a total of 8,509 common shares of the company, with 8,509 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925067430/xslF345X05/tm2520691-3_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oracle Unusual Options Activity
Oracle Unusual Options Activity
Jul 30, 2025
Whales with a lot of money to spend have taken a noticeably bullish stance on Oracle. Looking at options history for Oracle we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 30% with bearish. From the overall spotted trades, 2 are...
Science Applications International Signs Deal With Alphabet's Google to Train Personnel
Science Applications International Signs Deal With Alphabet's Google to Train Personnel
Jul 30, 2025
10:04 AM EDT, 07/30/2025 (MT Newswires) -- Science Applications International ( SAIC ) said Wednesday it formed a partnership with Google Public Sector, a division of Alphabet's Google ( GOOG ) Cloud. The company said it will use Google Cloud's technology to train and certify its personnel, and that its goal is to have 1,000 trained employees in cloud technology....
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Jul 30, 2025
JERUSALEM, July 30 (Reuters) - The CEO of Israel's Teva Pharmaceutical Industries said on Wednesday there was big ambiguity and so many unanswered questions in the drugs sector regarding potential U.S. tariffs, but the company was positioned for minimal impact. Richard Francis said 70% of Teva's generics business was outside of the United States while most of its branded drugs...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved